# OnCo record rivogenlecleucel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rivogenlecleucel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rivogenlecleucel" ;
  schema:name "Rivogenlecleucel"@en ;
  schema:alternateName "BPX-501"@en, "rivo-cel"@en, "BPX-501 T cells"@en ;
  schema:description "Rivogenlecleucel is an allogeneic polyclonal T cell therapy with an inducible caspase-9 safety switch from Bellicum Pharmaceuticals that reached phase 3 for acute myeloid leukaemia, acute lymphoblastic leukaemia and myelodysplastic syndromes and other cancers; development has stopped."@en ;
  schema:url <https://onco.cc/drugs/rivogenlecleucel/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1358403/000135840319000038/a2018q410k.htm>, <https://www.sec.gov/Archives/edgar/data/1358403/000135840319000038/a2018q410k.htm>, <https://www.sec.gov/Archives/edgar/data/1358403/000162828023010145/blcm-20221231.htm>, <https://clinicaltrials.gov/api/v2/studies/NCT03699475>, <https://clinicaltrials.gov/search?intr=BPX-501> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest", "discontinued" ;
  onco:modality "Allogeneic polyclonal T cell therapy with an inducible caspase-9 safety switch" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/bellicum/> ;
  onco:trials <https://onco.cc/trials/nct03699475/>, <https://onco.cc/trials/nct01744223/>, <https://onco.cc/trials/nct02065869/>, <https://onco.cc/trials/nct03301168/>, <https://onco.cc/trials/nct02477878/>, <https://onco.cc/trials/nct03459170/>, <https://onco.cc/trials/nct03733249/>, <https://onco.cc/trials/nct02786485/>, <https://onco.cc/trials/nct02487459/>, <https://onco.cc/trials/nct03807063/> .